RBM43: A Potential Drug Target Or Biomarker (G375287)

Target Name: RBM43

NCBI ID: G375287

RBM43

Other Name(s): RNA-binding protein 43 | C2orf38 | RBM43_HUMAN | RNA binding motif protein 43 | RNA-binding motif protein 43

RBM43: A Potential Drug Target Or Biomarker

RNA-binding protein 43 (RBM43) is a protein that is expressed in various tissues and cells throughout the body. It plays a critical role in the regulation of gene expression and has been associated with various diseases, including cancer.

One of the key functions of RBM43 is its ability to interact with RNA molecules. This interaction allows RBM43 to regulate the activity of other proteins and to control the translation of RNA into protein.

RBM43 has been shown to play a role in the regulation of cell growth and division. It has been shown to inhibit the activity of the oncogene transforming growth factor (TGF-2), which promotes cell growth and division.

In addition to its role in cell growth and division, RBM43 has also been shown to play a role in the regulation of cell survival. It has been shown to protect against the toxic effects of chemotherapy drugs, such as taxanes, by regulating the expression of genes involved in cell survival.

RBM43 has also been shown to play a role in the regulation of inflammation. It has been shown to regulate the activity of immune cells and to contribute to the regulation of inflammation.

In addition to its roles in cell growth, division, and survival, RBM43 has also been shown to play a role in the regulation of other important processes in the body, including the regulation of metabolism and the regulation of cellular signaling pathways.

Given its diverse range of functions and the evidence suggesting its relationship with many diseases, RBM43 is considered a potential drug target or biomarker. Currently, there are many studies dedicated to exploring the role of RBM43 in the treatment of cancer, metabolic diseases, and immune-related diseases. potential role.

Among them, some studies are exploring the use of anti-tumor drugs to inhibit the activity of RBM43 to treat various cancers, including breast, lung and prostate cancer. In addition, some studies are exploring the use of RBM43 as a biomarker for the treatment of metabolic diseases and immune-related diseases, including diabetes, obesity, and autoimmune diseases.

Although the identity of the drug target or biomarker of RBM43 is currently unclear, its discovery and research provide new ideas and methods for the treatment of various diseases. As technology continues to advance, we may discover more roles and potential of RBM43 in medicine in the future.

Protein Name: RNA Binding Motif Protein 43

The "RBM43 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBM43 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets